Nanocarriers of Antifungal Agents

  • Sevgi Güngör
  • M. Sedef Erdal


Fungal infections are still one of the major healthcare problems worldwide. Particularly, the treatment of invasive fungal infections has become more difficult in high-risk patient groups such as AIDS patients, organ transplant recipients, and cancer patients undergoing immunosuppressive chemotherapy. Superficial fungal infections have a less tendency to develop to systemic infection, but they could be serious due to the inefficiency of the treatment. In addition, the controlling of drug release is also important to minimize systemic absorption and to decrease the toxicity of these agents. Therefore, delivery of antifungal agents used for the treatment of superficial and systemic infections has a great impact in terms of both therapeutic aspect and safety. The novel nano-sized drug carriers play a key role to overcome the limitations of conventional dosage forms to improve the efficacy and to ensure safety of the treatment. In the present chapter, the limitations of conventional drug carriers of fungal agents are concisely emphasized, and the impact of nano-sized carriers in delivering antifungal agents has been addressed, paying particular attention toward the studies performed in recent literature.


Fungal Infection Antifungal Agent Invasive Fungal Infection Solid Lipid Nanoparticles Nanostructured Lipid Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adler-Moore JP, Proffitt RT (2004) Novel drug delivery systems for antifungal agents. In: Domer JE, Kobayashi GS (eds) The mycota XII human fungal pathogens. Springer, Heidelberg, pp 339–340CrossRefGoogle Scholar
  2. Aggarwal N, Goindi S (2012) Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis dermatophytosis. Int J Pharm 437(1–2):277–287CrossRefPubMedGoogle Scholar
  3. Aggarwal N, Goindi S (2013) Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. J Biomed Nanotechnol 9(4):564–576CrossRefPubMedGoogle Scholar
  4. Aggarwal N, Goindi S, Khurana R (2013) Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application. Colloids Surf B 105:158–166CrossRefGoogle Scholar
  5. Ainbinder D, Paolino D, Fresta M et al (2010) Drug delivery applications with ethosomes. J Biomed Nanotechnol 6:558–568CrossRefPubMedGoogle Scholar
  6. Akhtar N (2014) Vesicles: a recently developed novel carrier for enhanced topical drug delivery. Curr Drug Deliv 11:87–97CrossRefPubMedGoogle Scholar
  7. Alomrani AH, Shazly GA, Amara AA, Badran MM (2014) Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids Surf B 121:74–81CrossRefGoogle Scholar
  8. Arendrup MC (2013) Candida and candidaemia. Susceptibility and epidemiology. Dan Med J 60(11):B4698PubMedGoogle Scholar
  9. Bachhav YG, Patravale VB (2009) Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm 365(1–2):175–179CrossRefPubMedGoogle Scholar
  10. Bachhav YG, Mondon K, Kalia YN et al (2011) Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J Control Release 153(2):126–132CrossRefPubMedGoogle Scholar
  11. Barakat HS, Darwish IA, El-Khordagui LK et al (2009) Development of naftifine hydrochloride alcohol-free niosome gel. Drug Dev Ind Pharm 35(5):631–637CrossRefPubMedGoogle Scholar
  12. Barot BS, Parejiya PB, Patel HK et al (2012a) Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS PharmSciTech 13(1):184–192CrossRefPubMedGoogle Scholar
  13. Barot BS, Parejiya PB, Patel HK et al (2012b) Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies. Drug Deliv Transl Res 2(6):463–476CrossRefPubMedGoogle Scholar
  14. Basha M, Abd El-Alim SH, Shamma RN et al (2013) Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res 23(3):203–210CrossRefPubMedGoogle Scholar
  15. Benson HA (2009) Elastic liposomes for topical and transdermal drug delivery. Curr Drug Deliv 6:217–226CrossRefPubMedGoogle Scholar
  16. Bhalaria MK, Naik S, Misra AN (2009) Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol 47(5):368–375PubMedGoogle Scholar
  17. Brito Oliveira M, Calixto G, Graminha M et al (2015) Development, characterization, and in vitro biological performance of fluconazole loaded microemulsions for the topical treatment of cutaneous leishmaniasis. Biomed Res Int. doi: 10.1155/2015/396894 Google Scholar
  18. Brüggemann RJM, Alffenaar JWC, Blijlevens NMA et al (2009) Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis 48:1441–1458CrossRefPubMedGoogle Scholar
  19. Carneiro G, Aguiar MG, Fernandes AP et al (2012) Drug delivery systems for the topical treatment of cutaneous leishmaniasis. Expert Opin Drug Deliv 9:1083–1097CrossRefPubMedGoogle Scholar
  20. Çelebi N, Ermiş S, Özkan S (2015) Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity. Drug Dev Ind Pharm 41(4):631–639CrossRefPubMedGoogle Scholar
  21. Cerdeira AM, Mazzotti M, Gander B (2013) Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm 443:209–220CrossRefPubMedGoogle Scholar
  22. Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13:257–388CrossRefPubMedGoogle Scholar
  23. Che J, Wu Z, Shao W et al (2015) Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole. Eur J Pharm Biopharm. doi: 10.1016/j.ejpb.2015.03.028 PubMedGoogle Scholar
  24. Chen YC, Liu DZ, Liu JJ et al (2012) Development of terbinafine solid lipid nanoparticles as a topical delivery system. Int J Nanomedicine 7:4409–4418PubMedPubMedCentralGoogle Scholar
  25. Chudasama A, Patel V, Nivsarkar M et al (2011) Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Technol Res 2(1):30–38CrossRefPubMedPubMedCentralGoogle Scholar
  26. Coneac G, Vlaia V, Olariu I et al (2015) Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole. AAPS PharmSciTech. doi: 10.1208/s12249-014-0275-8 PubMedPubMedCentralGoogle Scholar
  27. da Fonseca Antunes AB, De Geest BG, Vervaet C et al (2013) Solvent-free drug crystal engineering for drug nano- and micro suspensions. Eur J Pharm Sci 48(1–2):121–129CrossRefPubMedGoogle Scholar
  28. El-Hadidy GN, Ibrahim HK, Mohamed MI et al (2012) Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm 38(1):64–72CrossRefPubMedGoogle Scholar
  29. Elmoslemany RM, Abdallah OY, El-Khordagui LK et al (2012) Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes. AAPS PharmSciTech 13(2):723–731CrossRefPubMedPubMedCentralGoogle Scholar
  30. El-Nesr OH, Yahiya SA, El-Gazayerly ON (2010) Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes. Saudi Pharm J J18(4):217–224CrossRefGoogle Scholar
  31. El-Ridy MS, Abdelbary A, Essam T et al (2011) Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm 37(12):1491–1508CrossRefPubMedGoogle Scholar
  32. Fernández Campos F, Calpena Campmany AC, Rodríguez Delgado G et al (2012) Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. J Pharm Sci 101(10):3739–3752CrossRefPubMedGoogle Scholar
  33. Flückiger U, Marchetti O, Bille J, Eggimann P, Zimmerli S, Immof A, Garbino J, Ruef C, Pittet D, Tauber M, Glauser M, Calandra T (2006) Treatment options of invasive fungal infections in adults. Swiss Med Wkly 136:447–463PubMedGoogle Scholar
  34. Ghannoum M, Isham N, Verma A et al (2013) In vitro antifungal activity of naftifine hydrochloride against dermatophytes. Antimicrob Agents Chemother 57(9):4369–4372CrossRefPubMedPubMedCentralGoogle Scholar
  35. Güngör S, Erdal MS, Aksu B (2013) New formulation strategies in topical antifungal therapy. J Cosm Dermatol Sci Appl 3:56–65Google Scholar
  36. Güngör S, Erdal MS, Güngördük S (2015a) Colloidal carriers in topical treatment of dermatological diseases. In: Naik J (ed) Nano-based drug delivery. IAPC Open Book and Monograph Platform (OBP), Zagreb, pp 391–409Google Scholar
  37. Güngör S, Kahraman E, Özsoy Y (2015b) Polymeric micelles for cutaneous drug delivery. In: Naik J (ed) Nano-based drug delivery. IAPC Open Book and Monograph Platform (OBP), Zagreb, pp 369–387Google Scholar
  38. Guo F, Wang J, Ma M et al (2015) Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation. J Mater Sci Mater Med. doi: 10.1007/s10856-015-5487-2 Google Scholar
  39. Gupta M, Goyal AK, Paliwal SR et al (2010) Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res 20(4):341–350CrossRefPubMedGoogle Scholar
  40. Gupta M, Vaidya B, Mishra N et al (2011) Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol 39(6):376–384CrossRefPubMedGoogle Scholar
  41. Hashem FM, Shaker DS, Ghorab MK et al (2011) Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS PharmSciTech 12(3):879–886CrossRefPubMedPubMedCentralGoogle Scholar
  42. Hoeller S, Klang V, Valenta C (2008) Skin-compatible lecithin drug delivery systems for fluconazole: effect of phosphatidylethanolamine and oleic acid on skin permeation. J Pharm Pharmacol 60(5):587–591CrossRefPubMedGoogle Scholar
  43. Iqbal MA, Md S, Sahni JK et al (2012) Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target 20:813–830CrossRefPubMedGoogle Scholar
  44. Johal HS, Garg T, Rath G et al (2014) Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv 24:1–14Google Scholar
  45. Kang JW, Davaa E, Kim YT, Park JS (2010) A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel. J Drug Target 18(8):637–644CrossRefPubMedGoogle Scholar
  46. Karimunnisa S, Atmaram P (2013) Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal. Drug Dev Ind Pharm 39(9):1328–1337CrossRefPubMedGoogle Scholar
  47. Kasper L, Miramón P, Jablonowski N et al (2015) Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase, and morphology. J Med Microbiol. doi: 10.1099/jmm.0.000082 PubMedGoogle Scholar
  48. Kaur P, Kakkar S (2010) Topical delivery of antifungal agents. Expert Opin Drug Deliv 7:1303–1327CrossRefPubMedGoogle Scholar
  49. Kelly BP (2012) Superficial fungal infections. Pediatr Rev 33:22–37CrossRefGoogle Scholar
  50. Keshri L, Pathak K (2013) Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis. Pharm Dev Technol 18(3):634–644CrossRefPubMedGoogle Scholar
  51. Korting HC, Klovekornl W, Klovekorn G (1997) Comparative efficacy and tolerability of econazole liposomal gel 1%, branded econazole conventional cream 1% and generic clotrimazole cream 1% in tinea pedis. Clin Drug Invest 14:286–293CrossRefGoogle Scholar
  52. Koutsoulas C, Pippa N, Demetzos C et al (2014) Preparation of liposomal nanoparticles incorporating terbinafine in vitro drug release studies. J Nanosci Nanotechnol 14(6):4529–4533CrossRefPubMedGoogle Scholar
  53. Kumar N, Shishu (2015) D-optimal experimental approach for designing topical microemulsion of itraconazole: characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats. Eur J Pharm Sci 67:97–112CrossRefPubMedGoogle Scholar
  54. Kumar L, Verma S, Bhardwaj A, Vaidya S, Vaidya B (2014) Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artif Cells Nanomed Biotechnol 42(1):32–46CrossRefPubMedGoogle Scholar
  55. Lewis RE (2010) Polyene antifungal agents. In: ComarúPasqualotto A (ed) Aspergillosis: from diagnosis to prevention. Springer, Heidelberg, pp 281–305Google Scholar
  56. Madhu G, Agrawal U, Vyas S (2012) Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 9:783–804CrossRefGoogle Scholar
  57. Mahale NB, Thakkar PD, Mali RG et al (2012) Niosomes: novel sustained release nonionic stable vesicular systems – an overview. Adv Colloid Interf Sci 183–184:46–54CrossRefGoogle Scholar
  58. Maheshwari RG, Tekade RK, Sharma PA et al (2012) Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J 20(2):161–170CrossRefPubMedGoogle Scholar
  59. Marianecci C, Di Marzio L, Rinaldi F et al (2014) Niosomes from 80s to present: the state of the art. Adv Colloid Interf Sci 205:187–206CrossRefGoogle Scholar
  60. Mbah CC, Builders PF, Attama AA (2014) Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Expert Opin Drug Deliv 11:45–59CrossRefPubMedGoogle Scholar
  61. Melkoumov A, Goupil M, Louhichi F et al (2015) Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans. J Antimicrob Chemother. doi: 10.1093/jac/dkt137 Google Scholar
  62. Merisko-Liversidge E, Liversidge GG (2011) Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev 63:427–440CrossRefPubMedGoogle Scholar
  63. Munoz P, Guinea J, Rojas L et al (2010) New antifungal agents for the treatment of candidemia. Int J Antimicrob Agents 36:63–69CrossRefGoogle Scholar
  64. Neubert RH (2011) Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm 77:1–2CrossRefPubMedGoogle Scholar
  65. Pandit J, Garg M, Jain NK (2014) Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection. J Liposome Res 24(2):163–169CrossRefPubMedGoogle Scholar
  66. Patel MR, Patel RB, Parikh JR et al (2009) Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech 10(3):917–923CrossRefPubMedPubMedCentralGoogle Scholar
  67. Patel MR, Patel RB, Parikh JR et al (2011) Investigating effect of microemulsion components: in vitro permeation of ketoconazole. Pharm Dev Technol 16(3):250–258CrossRefPubMedGoogle Scholar
  68. Randhawa MA, Gondal MA, Al-Zahrani AH et al (2015) Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm. J Environ Sci Health Part A Toxic Hazard Subst Environ Eng 50(2):119–124CrossRefGoogle Scholar
  69. Sabale V, Vora S (2012) Formulation and evaluation of microemulsion-based hydrogel for topical delivery. Int J Pharm Invest 2(3):140–149CrossRefGoogle Scholar
  70. Sable CA, Strohmeier KM, Chodakewitz JA (2008) Advances in antifungal therapy. Annu Rev Med 59:361–379CrossRefPubMedGoogle Scholar
  71. Sahoo S, Pani NR, Sahoo SK (2014a) Effect of microemulsion in topical sertaconazole hydrogel: in vitro and in vivo study. Drug Deliv 20:1–8Google Scholar
  72. Sahoo S, Pani NR, Sahoo SK (2014b) Microemulsion based topical hydrogel of sertaconazole: formulation, characterization and evaluation. Colloids Surf B 120:193–199CrossRefGoogle Scholar
  73. Salerno C, Carlucci AM, Bregni C (2010) Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech 11(2):986–993CrossRefPubMedPubMedCentralGoogle Scholar
  74. Sanna V, Gavini E, Cossu M et al (2007) Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J Pharm Pharmacol 59(8):1057–1064CrossRefPubMedGoogle Scholar
  75. Santos P, Watkinson AC, Hadgraft J et al (2008) Application of microemulsions in dermal and transdermal drug delivery. Skin Pharmacol Physiol 21:246–259CrossRefPubMedGoogle Scholar
  76. Scalia S, Young PM, Traini D (2015) Solid lipid microparticles as an approach to drug delivery. Expert Opin Drug Deliv 12:583–599CrossRefPubMedGoogle Scholar
  77. Schwarz JC, Kählig H, Matsko NB et al (2011) Decrease of liposomal size and retarding effect on fluconazole skin permeation by lysine derivatives. J Pharm Sci 100(7):2911–2919CrossRefPubMedGoogle Scholar
  78. Shaikh KS, Chellampillai B, Pawar AP (2010) Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm 36(8):946–953CrossRefPubMedGoogle Scholar
  79. Sharma R, Pathak K (2011) Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 16(4):367–376CrossRefPubMedGoogle Scholar
  80. Sheehan DJ, Hitchcock CA, Sibley CM (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev 12(1):40–79PubMedPubMedCentralGoogle Scholar
  81. Song CK, Balakrishnan P, Shim CK et al (2012) A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B 92:299–304CrossRefGoogle Scholar
  82. Song SH, Lee KM, Kang JB et al (2014) Improved skin delivery of voriconazole with a nanostructured lipid carrier-based hydrogel formulation. Chem Pharm Bull 62(8):793–798CrossRefPubMedGoogle Scholar
  83. Souto EB, Wissing SA, Barbosa CM et al (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 278(1):71–77CrossRefPubMedGoogle Scholar
  84. Stock I (2010) Fungal diseases of vulva and vagina caused by Candida species. Med Monatsschr Pharm 33(9):324–333PubMedGoogle Scholar
  85. Sudhakar B, Varma JN, Murthy KV (2014) Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery. Curr Drug Deliv 11(4):521–530CrossRefPubMedGoogle Scholar
  86. Tanrıverdi ST, Özer Ö (2013) Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis. Eur J Pharm Sci 48(4–5):628–636CrossRefPubMedGoogle Scholar
  87. Thompson GR, Cadena J, Patterson TF (2009) Overview of antifungal agents. Clin Chest Med 30:203–215CrossRefPubMedGoogle Scholar
  88. Torrado JJ, Espada R, Ballesteros MP et al (2008) Amphotericin B formulations and drug targeting. J Pharm Sci 97:2405–2425CrossRefPubMedGoogle Scholar
  89. Vanić Ž, Škalko-Basnet N (2013) Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur J Pharm Sci 50(1):29–41CrossRefPubMedGoogle Scholar
  90. Verma P, Pathak K (2012) Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 8:489–496PubMedGoogle Scholar
  91. Zhang AY, Camp WL, Elewski BE (2007) Advances in topical and systemic antifungals. Dermatol Clin 25:165–183CrossRefPubMedGoogle Scholar
  92. Zhang JP, Wei YH, Zhou Y et al (2012) Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study. Arch Pharm Res 35(1):109–117CrossRefPubMedGoogle Scholar
  93. Zonios DI, Bennett JE (2008) Update on azole antifungals. Semin Respir Crit Care Med 29(2):198–210CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Faculty of Pharmacy, Department of Pharmaceutical TechnologyIstanbul UniversityIstanbulTurkey

Personalised recommendations